Investigation of the usefulness of liver-specific deconvolution method toward legacy data utilization
Ontology highlight
ABSTRACT:
ORGANISM(S): Mus musculus
PROVIDER: GSE237801 | GEO | 2023/07/31
REPOSITORIES: GEO
Similar Datasets
Project description:Toxicogenomics databases are useful for understanding biological responses in individuals because they are derived from well-controlled experiments and include a diverse spectrum of biological responses. Although these databases contain no information regarding immune cells in the liver, which are important in the progression of liver injury, deconvolution that estimates cell-type proportions from bulk transcriptome could add information regarding immune cell trafficking to the database. However, deconvolution has been mainly applied to humans and mice and less often to rats, which are the main target of toxicogenomics databases. Here, we developed a deconvolution method for rats and established a methodology to obtain information regarding immune cells from toxicogenomics databases. The contributions of this work are three-fold. First, we obtained the gene expression profiles of various rat immune cells necessary for deconvolution and constructed a dataset; second, we compared the accuracy of models based on human and mouse datasets and showed the impact of species differences on deconvolution; third, we showed that rat deconvolution could retrieve information regarding immune cell trafficking from toxicogenomics databases. Correspondence: Tadahaya Mizuno
2023-08-15 | GSE239996 | GEO
Project description:Deconvolution is the problem of estimating proportions of mixed cell types from tissue samples. DNA methylation is commonly used for deconvolution because individual CpG sequences can reflect cell type identity and can be accurately measured at either the population or single-molecule level. Genomic sequencing techniques can profile multiple CpGs on a single DNA molecule, but few deconvolution models have been developed to exploit these single-molecule methylation haplotypes for cell type deconvolution. We use simulated whole-genome methylation data and in silico mixtures of real data to compare existing computational tools with two new models developed here. We find that adapting an existing model CelFiE to incorporate methylation haplotype information improves deconvolution accuracy by ~30% over the original CelFiE and the next best tool. Our new tool, CelFiE Integrated Single-molecule Haplotypes (or CelFiE-ISH), also outperforms other tools in detecting rare cell types present at 0.1% and below, which can be used to improve detection of rare cell types in circulating DNA. CelFiE-ISH is publicly available under a permissive open-source license. Finally, we investigate the selection of cell-type specific marker regions from the genome, a prerequisite for all of these tools. We find that the selection method used has a strong effect on accuracy in our benchmarks, and identify specific marker features that contribute to deconvolution accuracy. We show that tailoring the marker selection method to specific attributes of the deconvolution model, such as the use of DNA methylation haplotypes, can improve deconvolution accuracy.
2023-08-02 | GSE239605 | GEO
Project description:Difference in RNA content of different cell types introduces bias to gene expression deconvolution methods. If ERCC spike-ins are introduced into samples, predicted proportions of deconvolution methods can be corrected
2019-04-03 | GSE129240 | GEO
Project description:Genome-scale deconvolution of RNA structure ensembles
| PRJNA663861 | ENA
Project description:Transcriptomic deconvolution of human endometrial cell types
| PRJNA668163 | ENA
Project description:Gene expression microarray has been the primary biomarker platform ubiquitously applied in biomedical research, resulting in enormous data, predictive models and biomarkers accrued. Recently, RNA-seq has looked likely to replace microarrays, but there will be a period where both technologies coexist. This raises two important questions: can microarray-based models and biomarkers be directly applied to RNA-Seq data? Can future RNA-Seq-based predictive models and biomarkers be applied to microarray data to leverage past investment? We systematically evaluated the transferability of predictive models and signature genes between microarray and RNA-seq using two large clinical data sets. The complexity of cross-platform sequence correspondence was considered in the analysis and examined using three human and two rat data sets, and three levels of mapping complexity were revealed. Three algorithms representing different modeling complexity were applied to the three levels of mappings for each of the eight binary endpoints and Cox regression was used to model survival times with expression data. In total, 240,096 predictive models were examined. Signature genes of predictive models are reciprocally transferable between microarray and RNA-seq data for model development, and microarray-based models can accurately predict RNA-seq-profiled samples; while RNA-seq-based models are less accurate in predicting microarray-profiled samples and are affected both by the choice of modeling algorithm and the gene mapping complexity. The results suggest continued usefulness of legacy microarray data and established microarray biomarkers and predictive models in the forthcoming RNA-seq era. Definitions of characteristics: EFS day: number of days for event free survival EFS bin: binary classification of event free survival OS day: number of days for overall survival OS bin: binary classification of overall survival High Risk: Indicating whether a sample belongs to high risk group or not A_EFS_All: binary class label for event free survival for all samples B_OS_All: binary class label for overall survival for all samples C_SEX_All: binary class label for sex D_FAV_All: binary class label for favorable and unfavorable samples E_EFS_HR: binary class label for event free survival of High Risk group F_OS_HR: binary class label for overall survival of High Risk group. The same set of Samples is submitted under GEO accession GSE49711. This Series is a reanalysis of the data. The same set of RNA samples were profiled with microarray and RNA-Seq platforms. We explore the transferability of predictive models and signature genes between microarray and RNA-Seq data
2014-10-22 | E-GEOD-62564 | biostudies-arrayexpress
Project description:We benchmarked deconvolution algorithms on human brain gene expression data. The data deposited here include A) mixtures on which algorithms were benchmarked, as well as B) signatures of pure brain cell-type expression
2021-08-28 | GSE175772 | GEO
Project description:RNA profiling technologies at single-cell resolutions, including single-cell and single-nuclei RNA sequencing (scRNA-Seq and snRNA-Seq, scnRNA-Seq for short), can help characterize the composition of tissues and reveal cells that influence key healthy and disease functions. However, the use of these technologies is challenging because of their relatively high costs and exacting sample collection requirements. Computational deconvolution methods that infer the composition of RNA-Seq-profiled samples using scnRNA-Seq-characterized cell types can expand the benefit of these technologies, but their effectiveness remains controversial. We produced the first systematic evaluation of deconvolution methods on datasets with either known compositions or based on concurrent RNA-Seq and scnRNA-Seq profiles. Our analyses revealed biases that are common to scnRNA-Seq 10X Genomics assays and illustrated the importance of accurate and properly controlled data preprocessing and method selection and optimization. Moreover, our results suggested that concurrent RNA-Seq and scnRNA-Seq profiles can help improve the accuracy of both scnRNA-Seq preprocessing and the deconvolution methods that employ them. Indeed, our proposed method, Single-cell RNA Quantity Informed Deconvolution (SQUID), combined RNA-Seq transformation and a dampened weighted least squares deconvolution approach to consistently outperform other methods in predicting the composition of cell mixtures and tissue samples. Moreover, our analysis suggested that only SQUID could identify outcomes-predictive cancer cell subtypes in pediatric acute myeloid leukemia and neuroblastoma datasets.
2023-04-28 | GSE220607 | GEO
Project description:Gene expression microarray has been the primary biomarker platform ubiquitously applied in biomedical research, resulting in enormous data, predictive models and biomarkers accrued. Recently, RNA-seq has looked likely to replace microarrays, but there will be a period where both technologies coexist. This raises two important questions: can microarray-based models and biomarkers be directly applied to RNA-Seq data? Can future RNA-Seq-based predictive models and biomarkers be applied to microarray data to leverage past investment? We systematically evaluated the transferability of predictive models and signature genes between microarray and RNA-seq using two large clinical data sets. The complexity of cross-platform sequence correspondence was considered in the analysis and examined using three human and two rat data sets, and three levels of mapping complexity were revealed. Three algorithms representing different modeling complexity were applied to the three levels of mappings for each of the eight binary endpoints and Cox regression was used to model survival times with expression data. In total, 240,096 predictive models were examined. Signature genes of predictive models are reciprocally transferable between microarray and RNA-seq data for model development, and microarray-based models can accurately predict RNA-seq-profiled samples; while RNA-seq-based models are less accurate in predicting microarray-profiled samples and are affected both by the choice of modeling algorithm and the gene mapping complexity. The results suggest continued usefulness of legacy microarray data and established microarray biomarkers and predictive models in the forthcoming RNA-seq era. Definitions of characteristics: EFS day: number of days for event free survival EFS bin: binary classification of event free survival OS day: number of days for overall survival OS bin: binary classification of overall survival High Risk: Indicating whether a sample belongs to high risk group or not A_EFS_All: binary class label for event free survival for all samples B_OS_All: binary class label for overall survival for all samples C_SEX_All: binary class label for sex D_FAV_All: binary class label for favorable and unfavorable samples E_EFS_HR: binary class label for event free survival of High Risk group F_OS_HR: binary class label for overall survival of High Risk group. The same set of Samples is submitted under GEO accession GSE49711. This Series is a reanalysis of the data.
2014-10-22 | GSE62564 | GEO